That earnings report, unveiled well before market open that day, revealed that GeneDx booked nearly $103 million in revenue.

Recently, scientists have discovered a new organism that exists in this gray area between alive and not. Researchers are ...

Management raised full-year 2025 total revenue guidance to $400 million–$415 million and exome/genome revenue growth guidance to 48%–52%, with expected exome and genome revenue of $345 million–$355 ...

He described how we move forward to increase the use of CRISPR in the clinic and how to streamline the process by which this ...

Komor and Gaudelli developed the first iterations of base editing, providing the basis for engineering specific genomic base substitutions.

A massive genetic study found that stuttering is not just about nurture and may link to processing rhythm itself.

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded ...

Since its development a decade ago, CRISPR-cas9 has had many uses. In food, it can not only improve crop resilience to things ...

In the same vein as weather forecast models that predict developing storms, researchers now have developed a method to predict the cell activity in tissues over time.

The binding of proteins to DNA is crucial for producing other proteins, ensuring that all the necessary processes in cells ...

An team of scientists found a family of genome sequences known as “transposable elements.” They play a vital role in gene ...

Australian researchers have discovered a promising new strategy to suppress the growth of aggressive and hard-to-treat ...